JP2006507839A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006507839A5 JP2006507839A5 JP2004557456A JP2004557456A JP2006507839A5 JP 2006507839 A5 JP2006507839 A5 JP 2006507839A5 JP 2004557456 A JP2004557456 A JP 2004557456A JP 2004557456 A JP2004557456 A JP 2004557456A JP 2006507839 A5 JP2006507839 A5 JP 2006507839A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- hinge region
- composition
- exogenous
- modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 claims 38
- 239000000203 mixture Substances 0.000 claims 30
- 241000124008 Mammalia Species 0.000 claims 17
- 230000009261 transgenic effect Effects 0.000 claims 15
- 235000013336 milk Nutrition 0.000 claims 14
- 239000008267 milk Substances 0.000 claims 14
- 210000004080 milk Anatomy 0.000 claims 14
- 210000002919 epithelial cell Anatomy 0.000 claims 9
- 239000012634 fragment Substances 0.000 claims 9
- 235000001014 amino acid Nutrition 0.000 claims 8
- 150000001413 amino acids Chemical class 0.000 claims 8
- 230000013595 glycosylation Effects 0.000 claims 6
- 238000006206 glycosylation reaction Methods 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 4
- 150000007523 nucleic acids Chemical group 0.000 claims 4
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 4
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 4
- 210000004602 germ cell Anatomy 0.000 claims 3
- 210000001082 somatic cell Anatomy 0.000 claims 3
- 108091026890 Coding region Proteins 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 1
- 241000283707 Capra Species 0.000 claims 1
- 102000004407 Lactalbumin Human genes 0.000 claims 1
- 108090000942 Lactalbumin Proteins 0.000 claims 1
- 102000008192 Lactoglobulins Human genes 0.000 claims 1
- 108010060630 Lactoglobulins Proteins 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 241000699670 Mus sp. Species 0.000 claims 1
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 1
- 241001494479 Pecora Species 0.000 claims 1
- 241000700159 Rattus Species 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- 102000007544 Whey Proteins Human genes 0.000 claims 1
- 108010046377 Whey Proteins Proteins 0.000 claims 1
- 239000005018 casein Substances 0.000 claims 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims 1
- 235000021240 caseins Nutrition 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 235000021119 whey protein Nutrition 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42960602P | 2002-11-27 | 2002-11-27 | |
| PCT/US2003/038198 WO2004050847A2 (en) | 2002-11-27 | 2003-11-26 | Modified antibodies stably produced in milk and methods of producing same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006507839A JP2006507839A (ja) | 2006-03-09 |
| JP2006507839A5 true JP2006507839A5 (https=) | 2007-04-05 |
Family
ID=32469344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004557456A Abandoned JP2006507839A (ja) | 2002-11-27 | 2003-11-26 | 乳中に安定して産生される改変抗体およびその製造方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050097625A1 (https=) |
| EP (1) | EP1565564A4 (https=) |
| JP (1) | JP2006507839A (https=) |
| CN (1) | CN1729298A (https=) |
| AU (1) | AU2003298787A1 (https=) |
| BR (1) | BR0316643A (https=) |
| CA (1) | CA2506629A1 (https=) |
| WO (1) | WO2004050847A2 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122007000007I2 (de) | 1986-04-09 | 2010-12-30 | Genzyme Corp | Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern |
| US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| NZ544924A (en) * | 2003-06-27 | 2009-03-31 | Biogen Idec Inc | Modified binding molecules comprising connecting peptides |
| WO2006074399A2 (en) * | 2005-01-05 | 2006-07-13 | Biogen Idec Ma Inc. | Multispecific binding molecules comprising connecting peptides |
| US20080019905A9 (en) * | 2005-02-18 | 2008-01-24 | Strome Scott E | Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection |
| KR20140133958A (ko) * | 2005-10-21 | 2014-11-20 | 엘에프비 유에스에이, 인크. | 항체 의존성 세포 독성 활성이 증강된 항체, 그 생산 및 사용 방법 |
| AU2012201010B2 (en) * | 2005-10-21 | 2015-01-22 | Genzyme Corporation | Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
| ES2548714T3 (es) * | 2006-09-01 | 2015-10-20 | Zymogenetics, Inc. | Anticuerpos monoclonales IL-31 y procedimientos de uso |
| US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
| US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
| AU2008311367B2 (en) | 2007-10-05 | 2014-11-13 | Ac Immune S.A. | Use of anti-amyloid beta antibody in ocular diseases |
| EP2279003A4 (en) * | 2008-05-01 | 2013-04-03 | Gtc Biotherapeutics Inc | ANTI-CD137 ANTIBODY AS A MEANS FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| EP2598882B1 (en) | 2010-07-30 | 2017-07-26 | AC Immune S.A. | Safe and functional humanized antibodies for use in treating an amyloidosis |
| ES2811526T3 (es) | 2010-12-30 | 2021-03-12 | Lab Francais Du Fractionnement | Glicoles como agentes de inactivación de patógenos |
| CN104168913A (zh) * | 2011-08-10 | 2014-11-26 | 法国化学与生物科技实验室 | 高半乳糖基化抗体 |
| US10034921B2 (en) | 2013-02-13 | 2018-07-31 | Laboratoire Français Du Fractionnement Et Des Biotechnologies | Proteins with modified glycosylation and methods of production thereof |
| EP3594230A1 (en) * | 2013-02-13 | 2020-01-15 | Laboratoire Français du Fractionnement et des Biotechnologies | Highly galactosylated anti-tnf-alpha antibodies and uses thereof |
| CN105358577A (zh) * | 2013-02-13 | 2016-02-24 | 法国化学与生物科技实验室 | 具有经修饰的糖基化的西妥昔单抗及其用途 |
| EP3016729B1 (fr) | 2013-07-05 | 2020-03-25 | Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme | Matrice de chromatographie d'affinité |
| FR3025515B1 (fr) | 2014-09-05 | 2016-09-09 | Lab Francais Du Fractionnement | Procede de purification d'un anticorps monoclonal |
| US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| FR3034420A1 (fr) | 2015-03-31 | 2016-10-07 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-cd303 |
| FR3034419B1 (fr) | 2015-04-02 | 2017-12-15 | Lab Francais Du Fractionnement | Procede de purification d'une proteine recombinante therapeutique a partir d'un lait transgenique |
| FR3038517B1 (fr) | 2015-07-06 | 2020-02-28 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Utilisation de fragments fc modifies en immunotherapie |
| US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| WO2017194593A1 (en) | 2016-05-11 | 2017-11-16 | Ge Healthcare Bioprocess R&D Ab | Method of cleaning and/or sanitizing a separation matrix |
| US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
| WO2017194592A1 (en) | 2016-05-11 | 2017-11-16 | Ge Healthcare Bioprocess R&D Ab | Method of storing a separation matrix |
| US10513537B2 (en) | 2016-05-11 | 2019-12-24 | Ge Healthcare Bioprocess R&D Ab | Separation matrix |
| JP7031934B2 (ja) | 2016-05-11 | 2022-03-08 | サイティバ・バイオプロセス・アールアンドディ・アクチボラグ | 分離マトリックス |
| US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US12448411B2 (en) | 2016-09-30 | 2025-10-21 | Cytiva Bioprocess R&D Ab | Separation method |
| FR3060394B1 (fr) | 2016-12-16 | 2019-05-24 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Combinaison d'anticorps anti-cd303 et anti-amhrii |
| FR3060395B1 (fr) | 2016-12-16 | 2019-05-24 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Combinaison d'anticorps anti-cd303 et anti-her2 |
| FR3076294B1 (fr) | 2017-12-29 | 2022-01-28 | Lab Francais Du Fractionnement | Procede de purification d'anticorps a partir de lait brut |
| CA3223956A1 (en) | 2021-12-20 | 2023-06-29 | Vetoquinol Sa | Anti-canine interleukine-31-receptor a (il-31ra) antibodies and the uses thereof |
| EP4662240A2 (fr) | 2023-02-09 | 2025-12-17 | Commissariat à l'Energie Atomique et aux Energies Alternatives | Fragment fab mutant pour l'obtention de conjugués mono- ou bi-fonctionnalisés site-spécifiques |
| WO2025114614A1 (en) | 2023-11-30 | 2025-06-05 | Vetoquinol Sa | Anti-canine interleukine-4-receptor alpha (il-4rα) antibodies and the uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2459619B1 (fr) * | 1979-06-26 | 1983-07-29 | Agronomique Inst Nat Rech | Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede |
| DE3432718C1 (de) * | 1984-09-06 | 1986-05-22 | Biotest Pharma GmbH, 6000 Frankfurt | Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen |
| GB8823869D0 (en) * | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US4897465A (en) * | 1988-10-12 | 1990-01-30 | Abbott Laboratories | Enrichment and concentration of proteins by ultrafiltration |
| US5827690A (en) * | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| AU692841B2 (en) * | 1994-03-09 | 1998-06-18 | Abbott Laboratories | Transgenic animals producing oligosaccharides and glycoconjugates |
| AU707440B2 (en) * | 1994-03-29 | 1999-07-08 | Celltech Therapeutics Limited | Antibodies against E-selectin |
| RU2189251C2 (ru) * | 1994-12-23 | 2002-09-20 | Зенека Лимитед | Химические соединения |
| US6268487B1 (en) * | 1996-05-13 | 2001-07-31 | Genzyme Transgenics Corporation | Purification of biologically active peptides from milk |
-
2003
- 2003-11-26 CA CA002506629A patent/CA2506629A1/en not_active Abandoned
- 2003-11-26 BR BR0316643-0A patent/BR0316643A/pt not_active IP Right Cessation
- 2003-11-26 WO PCT/US2003/038198 patent/WO2004050847A2/en not_active Ceased
- 2003-11-26 EP EP03796545A patent/EP1565564A4/en not_active Withdrawn
- 2003-11-26 US US10/722,903 patent/US20050097625A1/en not_active Abandoned
- 2003-11-26 CN CN200380107311.8A patent/CN1729298A/zh active Pending
- 2003-11-26 JP JP2004557456A patent/JP2006507839A/ja not_active Abandoned
- 2003-11-26 AU AU2003298787A patent/AU2003298787A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006507839A5 (https=) | ||
| JP6473423B2 (ja) | 修飾された免疫グロブリン重鎖配列を有する非ヒト動物 | |
| KR102276752B1 (ko) | 단일 도메인 결합 단백질을 생산하는 비-인간 동물 | |
| LTC3284753I2 (https=) | ||
| WO2003040169A3 (en) | Human monoclonal antibodies to dendritic cells | |
| NO20040752L (no) | Humane antistoffer spesifikke for interleukin 15 (IL-15) | |
| WO2004076620A3 (en) | Human antibodies specific for interleukin 15 (il-15) | |
| DK1210374T3 (da) | Humane, monoklonale antistoffer over for prostataspecifikt membranantigen | |
| ATE527278T1 (de) | Humane monoklonale antikörper gegen interleukin 8 (il-8) | |
| WO2003064606A3 (en) | Human monoclonal antibodies to prostate specific membrane antigen (psma) | |
| JP2009525758A5 (https=) | ||
| ATE553131T1 (de) | Humane monoklonale antikörper gegen dendritische zellen | |
| WO2004056847A3 (en) | Human monoclonal antibodies to epidermal growth factor receptor (egfr) | |
| CN109906030A (zh) | 用于产生仅重链抗体的经基因修饰的非人动物和方法 | |
| PL392809A1 (pl) | Przeciwciało monoklonalne przeciwko CD40 i jego część wiążąca antygen, zawierająca go kompozycja i jego zastosowanie, oraz linia komórkowa, cząsteczka kwasu nukleinowego, wektor komórka gospodarza i sposób wytwarzania | |
| RU2017106292A (ru) | Мыши, у которых вырабатываются связывающие белки, содержащие vl-домены | |
| JP2010527622A5 (https=) | ||
| DE102009047243A1 (de) | Monospezifische Polypeptidreagenzien | |
| WO2008048871A3 (en) | Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses | |
| TH79238A (th) | แอนติบอดีของมนุษย์ที่จำเพาะสำหรับอินเตอร์ลิวคิน 15 (il-15) |